As of 2024-12-12, the Relative Valuation of Pharmadrug Inc (PHRX.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Pharmadrug Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-05 | -0.16 |
| 2024-11-04 | -0.12 |
| 2024-11-01 | -0.16 |
| 2024-10-31 | -0.16 |
| 2024-10-30 | -0.12 |
| 2024-10-29 | -0.16 |
| 2024-10-28 | -0.16 |
| 2024-10-25 | -0.20 |
| 2024-10-23 | -0.16 |
| 2024-10-22 | -0.20 |
| 2024-10-21 | -0.20 |
| 2024-10-18 | -0.20 |
| 2024-10-17 | -0.20 |
| 2024-10-16 | -0.16 |
| 2024-10-15 | -0.16 |
| 2024-10-11 | -0.16 |
| 2024-10-10 | -0.16 |
| 2024-10-08 | -0.16 |
| 2024-10-07 | -0.16 |
| 2024-10-04 | -0.12 |
| 2024-10-03 | -0.12 |
| 2024-10-01 | -0.12 |
| 2024-09-30 | -0.16 |
| 2024-09-27 | -0.16 |
| 2024-09-26 | -0.16 |
| 2024-09-25 | -0.16 |
| 2024-09-24 | -0.16 |
| 2024-09-23 | -0.16 |
| 2024-09-20 | -0.16 |
| 2024-09-19 | -0.20 |
| 2024-09-18 | -0.16 |
| 2024-09-17 | -0.16 |
| 2024-09-13 | -0.20 |
| 2024-09-12 | -0.16 |
| 2024-09-11 | -0.16 |
| 2024-09-10 | -0.16 |
| 2024-09-09 | -0.12 |
| 2024-09-06 | -0.16 |
| 2024-09-04 | -0.16 |
| 2024-09-03 | -0.20 |
| 2024-08-30 | -0.16 |
| 2024-08-29 | -0.20 |
| 2024-08-28 | -0.20 |
| 2024-08-27 | -0.16 |
| 2024-08-26 | -0.16 |
| 2024-08-23 | -0.20 |
| 2024-08-22 | -0.20 |
| 2024-08-21 | -0.24 |
| 2024-08-20 | -0.40 |
| 2024-08-19 | -0.20 |